In Vitro Activity of Ceftolozane/Tazobactam vs Nonfermenting, Gram-Negative Cystic Fibrosis Isolates
Keyword(s):
Abstract Ceftolozane/tazobactam (C/T) was tested and compared against 93 nonfermenting, Gram-negative clinical isolates from cystic fibrosis specimens. Based on current breakpoints for intra-abdominal and urinary tract infections (which may not be appropriate for pulmonary infections), C/T was found to be the most active agent against P. aeruginosa (95.7% susceptible), followed by piperacillin/tazobactam (89.4% susceptible). For other Gram-negative pathogens included, C/T had varying activity.
2013 ◽
Vol 17
(11)
◽
pp. e966-e970
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 49
(1)
◽
pp. 47-53
◽
1986 ◽
Vol 8
(Supplement_5)
◽
pp. S604-S608
◽
Keyword(s):
1988 ◽
Vol 22
(Supplement_D)
◽
pp. 199-207
◽
Keyword(s):
2000 ◽
Vol 16
(3)
◽
pp. 239-243
◽
Keyword(s):
Keyword(s):
2013 ◽
Vol 42
◽
pp. S54
2001 ◽
Vol 18
(3)
◽
pp. 263-266
◽
Keyword(s):